Welcome to our dedicated page for FOXO TECHNOLOGIES news (Ticker: FOXO), a resource for investors and traders seeking the latest updates and insights on FOXO TECHNOLOGIES stock.
FOXO Technologies Inc. (FOXO) generates news across healthcare services, behavioral health, biospecimen sourcing and biotechnology. Company announcements describe operations at its critical access hospital in East Tennessee, its behavioral health subsidiary, Myrtle Recovery Centers, its biospecimen provider Vector BioSource, Inc., and its biotechnology arm, FOXO Labs, Inc.
News items for FOXO often cover developments at Big South Fork Medical Center, including service expansions such as swing bed and wound care services and agreements like its Performance Network Agreement with Covenant Health to provide swing bed services within a broader performance network. Updates may also highlight patient volumes, service mix and new clinical offerings at the hospital.
FOXO’s behavioral health subsidiary, Myrtle Recovery Centers, Inc., appears frequently in company communications through license renewals, operational updates, and recognition from local and statewide organizations. News has included approval to receive Scott County Opioid Abatement Funds to support care for uninsured patients, as well as acknowledgments from associations such as the Rural Health Association of Tennessee.
On the life sciences side, FOXO issues press releases about its acquisition and growth of Vector BioSource, Inc., an information, data and biospecimen sourcing provider serving biotechnology, clinical research and pharmaceutical research sectors. These updates detail acquisition terms, revenue run-rate information, and planned funding for Vector’s growth initiatives.
FOXO also publishes news about FOXO Labs, Inc. and its epigenetics business, including the decision to pursue a spin-off of FOXO Labs, descriptions of its patent related to DNA epigenetic data, and its work on epigenetic biomarkers and AI-based wellness coaching concepts.
Corporate-level news for FOXO includes reverse stock split actions, changes to authorized share capital, preferred stock designations, and listing status updates, such as the transition of its common stock trading from NYSE American to the OTC market. Investors and observers can use the FOXO news feed on Stock Titan to follow these healthcare, biotechnology and corporate governance developments as they are disclosed in press releases and related SEC filings.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.